Skip to main content
Top

Breast Cancer Research

Issue 5/2000

Content (8 Articles)

Commentary

Metastases: the glycan connection

Christine Couldrey, Jeffrey E Green

Commentary

Nontransgenic models of breast cancer

Gloria H Heppner, Fred R Miller, PV Malathy Shekhar

Open Access Research article

Polymorphic repeat in AIB1 does not alter breast cancer risk

Christopher A Haiman, Susan E Hankinson, Donna Spiegelman, Graham A Colditz, Walter C Willett, Frank E Speizer, Myles Brown, David J Hunter

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine